NALCO & Pharma Stocks Surge on Massive Profit Reversals; SEBI Bars Zee Entertainment Amid Corporate Scrutiny
Quarterly Earnings Drive Market Sentiment: Divis Labs, Glenmark See Significant Jumps
The quarterly results released today showcase a varied picture across key sectors. While some companies faced profit decline, others delivered explosive growth. Divis Laboratories saw its Q1 (Consolidated YoY) Profit spike by 65.5%, reaching ₹902 crore from ₹545 crore, driven by a 27.8% rise in Revenue to ₹3,080 crore.National Aluminium Company (NALCO) reported dramatic results for Q1 (Consolidated YoY), with its Profit soaring 90.9% to ₹2,003.1 crore from ₹1,049.5 crore. Similarly, Glenmark Pharma’s Q1 (Consolidated YoY) saw profit grow over 10-fold to ₹482.9 crore compared to ₹46.9 crore, while revenue rose 23.1% to ₹4,018.5 crore.
Maruti Suzuki India announced results for Q1 (Standalone). The company’s Revenue surged 35.9% to ₹52,455.7 crore, but profit fell 10.8% to ₹3,352.1 crore from the previous quarter's ₹3,758.1 crore. ITC also reported a decline in profit for Q1 (Standalone), which dropped 27.1% to ₹3,578.8 crore versus ₹4,910.7 crore, while revenue (excluding excise duty) fell 14.4%.
Auto and Commodity Sector Performance Highlights
Automotive sales showed robust performance across several players in July. Eicher Motors witnessed a strong increase in total sales by 34% to 1,18,232 units, with domestic sales jumping 38.1% to 1,05,317 units. Tata Motors Passenger Vehicles reported a commanding 59% growth in total sales to 63,760 units, propelled by electric vehicle sales soaring 114% to 15,217 units.Maruti Suzuki India recorded a significant surge of 33.7% in total sales at 2.41 lakh units. Mahindra and Mahindra reported that their total automotive sales spiked 25.8% to 1,03,860 units. Hero MotoCorp’s overall sales increased by 18.6% to 5.33 lakh units.
The industrial sector saw mixed results. Indian Oil Corporation (IOC) recorded a loss of ₹2,661.3 crore in Q1 (Standalone), contrasting with the previous quarter's profit of ₹5,688.6 crore. Conversely, Muthoot Finance’s Q1 (Consolidated YoY) profit zoomed 38.8% to ₹2,799.1 crore, driven by a 29.6% jump in revenue to ₹5,098.6 crore.
Corporate Moves and Regulatory Scrutiny
The market activity included several significant corporate developments. Sterlite Technologies (STL) secured a multi-year supply agreement worth ₹960 crore for fibre cables to a domestic telecom operator. NCC announced the successful securing of three orders totaling ₹1,052.71 crore in July, with specific allocations for the buildings and water divisions.In pharmaceutical news, Dr Reddy's Laboratories received approval from the US Food and Drug Administration (FDA) for Rituximab, a biosimilar to Rituxan, indicating strong international market traction. Lupin also gained regulatory approval from the US FDA for Diazepam Injection USP in single-dose prefilled syringes.
A major event was the action taken against Zee Entertainment Enterprises (ZEEL). SEBI barred ZEEL, along with Punit Goenka and Essel Group founder Subhash Chandra, from the securities market. The regulator imposed a cumulative penalty of ₹1.48 crore after finding that company property was mortgaged without requisite corporate approvals.
Bulk Deals and Industrial News
In bulk transactions, Kotak Mahindra Mutual Fund acquired a 4.89% stake in Rossell Techsys for ₹166.24 crore from the promoters at ₹900 per share. Meanwhile, Belding India saw an investment where SageOne Investments purchased an additional 0.58% stake for ₹8.61 crore.Industrial activities reported by Coal India showed that coal production grew 8.4% to 50.4 MT, and the coal offtake jumped 17.4% to 63.7 MT. Bharat Electronics (BEL) secured additional orders worth ₹847 crore since July 13, covering electro-optics and security operations centres.
Other notable industry updates included a Power Purchase Agreement executed by Powerica with GUVNL for a 100 MW wind power project in Gujarat at a tariff of ₹3.435 per kWh for 25 years.
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.